299 related articles for article (PubMed ID: 21970488)
21. Mutational Profile and New IASLC/ATS/ERS Classification Provide Additional Prognostic Information about Lung Adenocarcinoma: A Study of 125 Patients from Brazil.
de Melo AC; Karen de Sá V; Sternberg C; Olivieri ER; Werneck da Cunha I; Fabro AT; Carraro DM; de Barros e Silva MJ; Pimenta Inada HK; de Mello ES; Soares FA; Takagaki T; Ferreira CG; Capelozzi VL
Oncology; 2015; 89(3):175-86. PubMed ID: 25833149
[TBL] [Abstract][Full Text] [Related]
22. Differential gene expression profiles according to the Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society histopathological classification in lung adenocarcinoma subtypes.
Molina-Romero C; Rangel-Escareño C; Ortega-Gómez A; Alanis-Funes GJ; Avilés-Salas A; Avila-Moreno F; Mercado GE; Cardona AF; Hidalgo-Miranda A; Arrieta O
Hum Pathol; 2017 Aug; 66():188-199. PubMed ID: 28603066
[TBL] [Abstract][Full Text] [Related]
23. IASLC/ATS/ERS International Multidisciplinary Classification of Lung Adenocarcinoma: novel concepts and radiologic implications.
Lee HJ; Lee CH; Jeong YJ; Chung DH; Goo JM; Park CM; Austin JH
J Thorac Imaging; 2012 Nov; 27(6):340-53. PubMed ID: 23086014
[TBL] [Abstract][Full Text] [Related]
24. Associations between epidermal growth factor receptor mutations and histological subtypes of lung adenocarcinoma according to the IASLC/ATS/ERS classification in Chinese patients.
Wang T; Zhang Y; Liu B; Hu M; Zhou N; Zhi X
Thorac Cancer; 2017 Nov; 8(6):600-605. PubMed ID: 28940943
[TBL] [Abstract][Full Text] [Related]
25. Association of IASLC/ATS/ERS Histologic Subtypes of Lung Adenocarcinoma With Epidermal Growth Factor Receptor Mutations in 320 Resected Cases.
Nakamura H; Saji H; Shinmyo T; Tagaya R; Kurimoto N; Koizumi H; Takagi M
Clin Lung Cancer; 2015 May; 16(3):209-15. PubMed ID: 25467929
[TBL] [Abstract][Full Text] [Related]
26. Cytologic subtyping of lung adenocarcinoma by using the proposed International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society (IASLC/ATS/ERS) adenocarcinoma classification.
Rodriguez EF; Monaco SE; Dacic S
Cancer Cytopathol; 2013 Nov; 121(11):629-37. PubMed ID: 23943235
[TBL] [Abstract][Full Text] [Related]
27. Cytopathology of pulmonary adenocarcinoma with a single histological pattern using the proposed International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society (IASLC/ATS/ERS) classification.
Rodriguez EF; Dacic S; Pantanowitz L; Khalbuss WE; Monaco SE
Cancer Cytopathol; 2015 May; 123(5):306-17. PubMed ID: 25788465
[TBL] [Abstract][Full Text] [Related]
28. Predictive value of the international association for the study of lung cancer/American Thoracic Society/European Respiratory Society classification of lung adenocarcinoma in tumor recurrence and patient survival.
Hung JJ; Yeh YC; Jeng WJ; Wu KJ; Huang BS; Wu YC; Chou TY; Hsu WH
J Clin Oncol; 2014 Aug; 32(22):2357-64. PubMed ID: 24799473
[TBL] [Abstract][Full Text] [Related]
29. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary.
Travis WD; Brambilla E; Noguchi M; Nicholson AG; Geisinger K; Yatabe Y; Powell CA; Beer D; Riely G; Garg K; Austin JH; Rusch VW; Hirsch FR; Jett J; Yang PC; Gould M;
Proc Am Thorac Soc; 2011 Sep; 8(5):381-5. PubMed ID: 21926387
[TBL] [Abstract][Full Text] [Related]
30. Correlation between EML4-ALK, EGFR and clinicopathological features based on IASLC/ATS/ERS classification of lung adenocarcinoma.
Wang H; Zhang W; Wang K; Li X
Medicine (Baltimore); 2018 Jun; 97(26):e11116. PubMed ID: 29952952
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society lung adenocarcinoma classification on death and recurrence in completely resected stage I lung adenocarcinoma.
Hung JJ; Jeng WJ; Chou TY; Hsu WH; Wu KJ; Huang BS; Wu YC
Ann Surg; 2013 Dec; 258(6):1079-86. PubMed ID: 23532112
[TBL] [Abstract][Full Text] [Related]
32. The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival.
Warth A; Muley T; Meister M; Stenzinger A; Thomas M; Schirmacher P; Schnabel PA; Budczies J; Hoffmann H; Weichert W
J Clin Oncol; 2012 May; 30(13):1438-46. PubMed ID: 22393100
[TBL] [Abstract][Full Text] [Related]
33. Nonpredominant lepidic pattern correlates with better outcome in invasive lung adenocarcinoma.
Mäkinen JM; Laitakari K; Johnson S; Mäkitaro R; Bloigu R; Lappi-Blanco E; Kaarteenaho R
Lung Cancer; 2015 Dec; 90(3):568-74. PubMed ID: 26506915
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification of stage I lung adenocarcinoma: A retrospective study based on analysis of 110 Chinese patients.
Zhao X; Zhang Y; Qian K; Zhao L; Wang W; Teng LH
Thorac Cancer; 2017 Nov; 8(6):565-571. PubMed ID: 28834269
[TBL] [Abstract][Full Text] [Related]
35. The clinical relevance of pathologic subtypes in metastatic lung adenocarcinoma.
Clay TD; Do H; Sundararajan V; Moore MM; Conron M; Wright GM; McLachlan SA; Dobrovic A; Russell PA
J Thorac Oncol; 2014 May; 9(5):654-63. PubMed ID: 24722155
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis of lung adenocarcinoma in resected specimens: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification.
Travis WD; Brambilla E; Noguchi M; Nicholson AG; Geisinger K; Yatabe Y; Ishikawa Y; Wistuba I; Flieder DB; Franklin W; Gazdar A; Hasleton PS; Henderson DW; Kerr KM; Nakatani Y; Petersen I; Roggli V; Thunnissen E; Tsao M
Arch Pathol Lab Med; 2013 May; 137(5):685-705. PubMed ID: 22913371
[TBL] [Abstract][Full Text] [Related]
37. CT Features Associated with Epidermal Growth Factor Receptor Mutation Status in Patients with Lung Adenocarcinoma.
Liu Y; Kim J; Qu F; Liu S; Wang H; Balagurunathan Y; Ye Z; Gillies RJ
Radiology; 2016 Jul; 280(1):271-80. PubMed ID: 26937803
[TBL] [Abstract][Full Text] [Related]
38. High expression of SLC34A2 is a favorable prognostic marker in lung adenocarcinoma patients.
Zhang Z; Ye S; Zhang M; Wu J; Yan H; Li X; He J
Tumour Biol; 2017 Jul; 39(7):1010428317720212. PubMed ID: 28720066
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of epidermal growth factor receptor mutations and histologic subtypes with lung adenocarcinoma.
Motono N; Funasaki A; Sekimura A; Usuda K; Uramoto H
Med Oncol; 2018 Jan; 35(3):22. PubMed ID: 29387978
[TBL] [Abstract][Full Text] [Related]
40. [Recommendation concerning the microscopic classification of lung adenocarcinoma presented by International Association for the Study of Lung Cancer, American Thoracic Society, and European Respiratory Society].
Langfort R; Szołkowska M
Pneumonol Alergol Pol; 2012; 80(2):99-100. PubMed ID: 22370977
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
